| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3938812 | Fertility and Sterility | 2012 | 8 Pages |
Abstract
These data demonstrate the first qPCR technology capable of accurate aneuploidy screening of all 24 chromosomes in 4 hours. This methodology provides an opportunity to evaluate trophectoderm biopsies with subsequent fresh euploid blastocyst transfer. Randomized controlled trials to investigate the clinical efficacy of qPCR-based CCS are currently underway.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Nathan R. Ph.D., Xin M.Sc., Kathleen M. B.Sc., Jing M.Sc., Deanne Ph.D., Richard T. M.D., H.C.L.D.,